(Q41107185)

26 September 2017

Mutational landscape and clonal architecture in grade II and III gliomas (English)

1 reference

26 September 2017

Tetsuichi Yoshizato

15

0 references

Teppei Shimamura

object named as

Teppei Shimamura

7

0 references

Kenichi Yoshida

object named as

Kenichi Yoshida

17

0 references

Toshihiko Wakabayashi

14

object named as

Toshihiko Wakabayashi

1 reference

26 September 2017

30

Atsushi Natsume

1 reference

26 September 2017

9

Kazuya Motomura

1 reference

26 September 2017

Hiromichi Suzuki

1

1 reference

26 September 2017

Kosuke Aoki

2

1 reference

26 September 2017

Kenichi Chiba

3

1 reference

26 September 2017

Yusuke Sato

4

1 reference

26 September 2017

Yusuke Shiozawa

5

1 reference

26 September 2017

Yuichi Shiraishi

6

1 reference

26 September 2017

Atsushi Niida

8

1 reference

26 September 2017

Fumiharu Ohka

10

1 reference

26 September 2017

Takashi Yamamoto

11

1 reference

26 September 2017

Kuniaki Tanahashi

12

1 reference

26 September 2017

Melissa Ranjit

13

1 reference

26 September 2017

Keisuke Kataoka

16

1 reference

26 September 2017

Yasunobu Nagata

18

1 reference

26 September 2017

Aiko Sato-Otsubo

19

1 reference

26 September 2017

Hiroko Tanaka

20

1 reference

26 September 2017

Masashi Sanada

21

1 reference

26 September 2017

Yutaka Kondo

22

1 reference

26 September 2017

Hideo Nakamura

23

1 reference

26 September 2017

Masahiro Mizoguchi

24

1 reference

26 September 2017

Tatsuya Abe

25

1 reference

26 September 2017

Yoshihiro Muragaki

26

1 reference

26 September 2017

Reiko Watanabe

27

1 reference

26 September 2017

Ichiro Ito

28

1 reference

26 September 2017

Satoru Miyano

29

1 reference

26 September 2017

Seishi Ogawa

31

1 reference

26 September 2017

language of work or name

English

0 references

publication date

13 April 2015

1 reference

26 September 2017

1 reference

26 September 2017

47

1 reference

26 September 2017

5

1 reference

26 September 2017

458-468

1 reference

https://scigraph.springernature.com/pub.10.1038/ng.3273

26 September 2017

0 references

cites work

Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001.

1 reference

7 January 2021

The 2007 WHO classification of tumours of the central nervous system

1 reference

7 January 2021

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

7 January 2021

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

7 January 2021

Adult supratentorial low-grade glioma: long-term experience at a single institution.

1 reference

7 January 2021

Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas

1 reference

7 January 2021

Glioblastoma and other malignant gliomas: a clinical review.

1 reference

7 January 2021

Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma

1 reference

7 January 2021

IDH1 and IDH2 mutations in gliomas

1 reference

7 January 2021

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

1 reference

7 January 2021

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations

1 reference

7 January 2021

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

1 reference

7 January 2021

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

1 reference

7 January 2021

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

1 reference

7 January 2021

Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma

1 reference

7 January 2021

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss

1 reference

7 January 2021

An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data

1 reference

7 January 2021

Integrated molecular analysis of clear-cell renal cell carcinoma

1 reference

7 January 2021

Frequent pathway mutations of splicing machinery in myelodysplasia

1 reference

7 January 2021

Mutational heterogeneity in cancer and the search for new cancer-associated genes

1 reference

7 January 2021

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

7 January 2021

The integrated landscape of driver genomic alterations in glioblastoma

1 reference

7 January 2021

The somatic genomic landscape of glioblastoma

1 reference

7 January 2021

Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance

1 reference

7 January 2021

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

1 reference

7 January 2021

Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas

1 reference

7 January 2021

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

1 reference

7 January 2021

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

1 reference

7 January 2021

Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses

1 reference

7 January 2021

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

1 reference

7 January 2021

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis

1 reference

7 January 2021

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

1 reference

7 January 2021

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma.

1 reference

7 January 2021

Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas

1 reference

7 January 2021

Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ mice.

1 reference

7 January 2021

Comprehensive genomic characterization of squamous cell lung cancers

1 reference

7 January 2021

Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1

1 reference

7 January 2021

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

1 reference

7 January 2021

Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

1 reference

7 January 2021

Identification of functional cooperative mutations of SETD2 in human acute leukemia

1 reference

7 January 2021

RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.

1 reference

7 January 2021

Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.

1 reference

7 January 2021

Random effects in paired-comparison experiments using the Bradley-Terry model

1 reference

7 January 2021

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

1 reference

7 January 2021

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

1 reference

7 January 2021

Evolution and dynamics of pancreatic cancer progression

1 reference

7 January 2021

Clonal evolution in breast cancer revealed by single nucleus genome sequencing.

1 reference

7 January 2021

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

1 reference

7 January 2021

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

1 reference

7 January 2021

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

1 reference

7 January 2021

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

1 reference

7 January 2021

Clinical and biological implications of driver mutations in myelodysplastic syndromes

1 reference

7 January 2021

A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays

1 reference

7 January 2021

Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays

1 reference

7 January 2021

Statistical model-based testing to evaluate the recurrence of genomic aberrations.

1 reference

7 January 2021

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

7 January 2021

The spectrum of SWI/SNF mutations, ubiquitous in human cancers

1 reference

7 January 2021

Chromatin modifier enzymes, the histone code and cancer

1 reference

7 January 2021

Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.

1 reference

7 January 2021

The landscape of somatic mutations in Down syndrome-related myeloid disorders.

1 reference

7 January 2021

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

1 reference

7 January 2021

Single column discrepancy and dynamic max-mini optimizations for quickly finding the most parsimonious evolutionary trees.

1 reference

7 January 2021

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

1 reference

7 January 2021

MEGA6: Molecular Evolutionary Genetics Analysis version 6.0

1 reference

7 January 2021

Identifiers

DOI

10.1038/NG.3273

1 reference

Dimensions Publication ID

26 September 2017

0 references

1 reference